Submitted by Anonymous (not verified) on 6 January 2026 - 10:40
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Vabysmo, faricimab, Date of authorisation: 15/09/2022, Revision: 8, Status: Authorised